Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer

Lignende værker

• Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report
  af: López-González, A., et al.
  Udgivet: (2013)
• Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
  af: Calvo, Virginia, et al.
  Udgivet: (2021)
• Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors
  af: Yun, Po-Jen, et al.
  Udgivet: (2019)
• Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
  af: Chen, Yulong, et al.
  Udgivet: (2021)
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
  af: Scagliotti, Giorgio, et al.
  Udgivet: (2010)